Filter
2277
Text search:
sars
Featured
323
61
Language
Document type
848
402
325
140
131
107
101
72
44
40
34
21
12
Countries / Regions
160
133
93
91
89
76
61
59
49
47
45
44
42
40
36
35
33
33
32
28
28
27
27
25
24
23
23
19
18
18
17
17
17
16
16
14
13
12
12
12
12
12
11
10
10
10
10
9
9
9
9
9
9
8
8
8
7
7
7
6
6
6
6
6
6
6
6
5
5
5
5
5
5
5
5
5
5
5
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
1124
78
53
43
31
30
20
2
Toolboxes
1723
62
49
42
37
36
35
31
31
18
17
16
14
12
12
11
10
8
8
8
4
3
3
2
Updated Treatment Guidelines
Drugs & Therapy Perspectives vol.36 (2020) 6
Memorandum: Recommendation of interval for the application of the booster dose of COVID-19 vaccines
Integrated Monitoring Flowchart for patients suspected of Dengue and/or COVID-19
Strategic Plan for COVID-19 vaccination in Argentina
Guidelines for the care of children and adolescents diagnosed with COVID - 19.
Prevention and Control of Covid-19 Transmission: Isolation and follow-up of suspected and/or confirmed cases and close contact tracing strategy
Vaccinator's Manual SINOPHARM Vaccine - 28 FEBRUARY 2021
Critical preparedness, readiness and response actions for COVID-19
Interim Guidance - 27 May 2021
Considerations on the implementation and adjustment of
public health and social measures in the context of
COVID-19
Interim guidance 14 June 2021
This guidance addresses rationale, risk-based scenarios, practical considerations prior to adoption of the self-testing products, quality assurance, safety and ethical considerations, and data management considerations for COVID-19 self-testing. The Africa CDC recommends the use of rapid antigen sel
...
26 de abril del 2022. La Organización Panamericana de la Salud presenta estas consideraciones con el fin de apoyar la toma de decisiones relativa al manejo de pacientes con COVID-19 en la Región de las Américas. Las recomendaciones tienen en cuenta la evidencia más reciente, el estado de vacunac
...
(Comirnaty® 10 мкг або 30 мкг виробництва BioNTech/Pfizer та Spikevax® виробництва Moderna);
Anamnese zur Schutzimpfung gegen COVID-19 (Corona Virus Disease 2019) (Grundimmunisierung und Auffrischimpfungen)
– mit mRNA-Impfstoffen –
(Comirnaty® 10 μg bzw.
...
– векторною вакциною – (Janssen® від COVID-19 виробництва Janssen Cilag International/Johnson & Johnson)
Anamnese zur Schutzimpfung gegen COVID-19 (Corona Virus Disease 2019) (Grundimmunisierung und Auffrischimpfungen)
– mit Vektor-Impfstoff – (COVID-19 Vacc
...
Biosafety involves the implementation of containment principles, technologies and practices to prevent unintentional exposure to biological agents. Biosecurity involves the protection, control and accountability of biological materials and information related to these materials and dualuse research,
...
As vacinas COVID-19 são eficazes contra novas variantes? O que significa para uma pessoa estar totalmente vacinada? Essa e outras dúvidas estão entre as dúvidas mais frequentes sobre a vacinação contra a COVID-19. Nesta sexta edição você encontrará respostas para essas e outras perguntas.
...
Ficha de Notificación e Investigación Epidemiológica Hepatitis Aguda Grave de origen Desconocido
Actualizatión 16.05.2022
